Apyx Medical Corporation Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Apyx Medical Corp. (APYX) Reports In-Line Q1 EPS, Revenues Beat; Offers 2Q Revenues Outlook
May 12, 2021 7:13 AM EDTApyx Medical Corp. (NASDAQ: APYX) reported Q1 EPS of ($0.14), in-line with the analyst estimate of ($0.14). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $7.84 million.
First Quarter 2021 Financial Summary:
Total revenue of $8.6 million, up 72.9% year-over-year.Advanced Energy revenue of $7.7 million, up 92.2% year-over-year.OEM revenue of $1.0 million, down 3.3% year-over-year.Net loss of $4.9 million, compared to net loss of $2.0 million for the first quarter of 2020. Net loss in the first quarter of 2020 included an income tax benefit of $4.9 million.Adjusted EBITDA... More